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Infiltrative dermopathy is an uncommon manifestation of Graves’ disease frequently involving the lower extremities. The natural course of this condition is not well-defined. It 
is seen usually after 2–3 years of onset of thyrotoxicosis. The 
pretibial area is the most commonly involved (99.4%) region [1,2]. 
Rarely the fingers, hands, elbows, arms, or face are affected. We 
report a case who presented with thyroid-associated orbitopathy 
and localized myxoedema over both the shoulders. The literature 
on Graves’ dermopathy indicates that this form of dermopathy is 
unusual [1,3,4].
CASE REPORT
A 45-year-old male presented to our outdoor department with 
complaints of palpitations, tremor, profuse sweating, and 
hyperdefecation. He gave a history of taking carbimazole 30 mg 
once daily and propranolol 40 mg once daily.
On physical examination, pulse rate was 104/min and 
regular, blood pressure was 116/74 mm of Hg. The patient had 
exophthalmos and the thyroid gland was diffusely enlarged with 
a firm texture, but no nodules were present (Fig. 1). The pretibial 
portion and feet were normal. Localized non-tender swelling was 
noted over both his shoulders (Fig. 2). On further enquiry, he 
revealed the history of carrying fish baskets tied to a pole over 
his shoulders.
The clinical features were suggestive of thyrotoxicosis and 
thyroid-associated orbitopathy. A skin biopsy was done from the 
shoulder lesion which showed deposits of eosinophilic hyaline 
material and mild perivascular inflammatory cell infiltration 
in the dermis suggestive of myxedema (Fig. 3). His clinical 
activity score (CAS) was 4/7, free T4 was 2.9 ng/dl, and thyroid 
stimulating hormone (TSH) was 0.013 micro IU/L.
Since the patient was having active Graves’ orbitopathy, 
he was started on weekly methylprednisolone therapy and 
was followed up for 12 weeks. During his follow-up visit 
after 1 month, his orbitopathy (CAS=1/7) and thyroid function 
improved (Free T4=1.5 ng/dl).
DISCUSSION
The patient presented in our case report had Graves’ 
ophthalmopathy and dermopathy. Moreover, he had the unusual 
presentation of localized myxedema involving both suprascapular 
areas. Graves’ disease is characterized by thyrotoxicosis, diffuse 
goiter, infiltrative orbitopathy and occasionally, and infiltrative 
dermopathy [5]. The least common manifestation of Graves’ 
disease is infiltrative dermopathy. It occurs in up to 4–5% 
of patients with Graves’ disease [1,2]. Skin thickening is the 
characteristic abnormality and is usually limited to the pretibial 
area (99.4%). Hence, it has been called pretibial myxedema. 
Localized myxedema is a more appropriate term as it involves 
other areas also occasionally [1,6].
Localized myxedema is an autoimmune manifestation of 
Graves’ disease, and the usual pretibial localization relates to 
mechanical factors and dependent position [7]. Rarely the fingers, 
hands, elbows, arms, or face are affected. The TSH receptor is 
the antigen for T-cell reaction, and TSH receptor antibodies are 
important in the pathogenesis of Graves’ dermopathy, similar 
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to that of Graves’ orbitopathy. This also explains the occasional 
worsening of dermopathy after trauma, surgery, and radioiodine 
therapy for hyperthyroidism [5,7,8].
Clinical features of infiltrative dermopathy are non-pitting 
scaly thickening and induration of the skin, papules, nodules, 
pigmentation, plaque, and rarely elephantiasis form [1,6]. 
Hyaluronic acid and chondroitin sulfate content in the dermis are 
increased leading to compression of the dermal lymphatics and 
non-pitting edema [1,5,7]. Differential diagnoses of infiltrative 
dermopathy are chronic lymphatic and venous obstruction of the 
lower extremities, chronic dermatitis, and cutaneous mucinosis. To 
establish the correct diagnosis, a skin biopsy may be necessary [9].
In a patient who has longstanding hyperthyroidism, the 
diagnosis of infiltrative dermopathy is usually confirmed by the 
location, non-pitting nature, and distinct borders of the lesions. In 
this case, both the location and nature of the lesion were atypical, 
and biopsy was necessary to establish the correct diagnosis and 
differentiate it from chronic dermatitis and cutaneous mucinosis. 
The histopathology of the skin showed deposits of eosinophilic 
hyaline material in the dermis with mild perivascular inflammatory 
cell infiltrate which were typical and diagnostic (Fig. 3). As most 
of these lesions are asymptomatic, no specific therapy is required. 
For symptomatic cases, topical corticosteroid therapy under 
occlusive or compressive dressings is recommended. Up to 50% 
of lesions go into complete or partial remission over time.
CONCLUSION
Graves’ dermopathy is a rare manifestation of the Graves’ disease. 
A skin biopsy is confirmatory of the condition. Since most of 
the times the lesions are asymptomatic, no specific therapy is 
required.
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Figure 1: The patient showing exophthalmos
Figure 2: Localized non-tender swelling over both the shoulders
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Figure 3: (a and b) Histopathology showing deposits of eosinophilic 
hyaline material and mild perivascular inflammatory cell infiltration 
in the dermis
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